TB-AI Showcases Groundbreaking Diagnostic Software at GITEX Africa 2024

Author Logo | Thu, 06 Jun 2024 12:52:22 GMT

Content provided by APO Group. CNBC Africa provides content from APO Group as a service to its readers and does not edit the articles it publishes. CNBC Africa is not responsible for the content provided by APO Group.

GITEX Africa

GITEX Africa

TB-AI, a pioneering startup from Pakistan, proudly announced its successful participation at GITEX Africa 2024 (https://GITEXAfrica.com/), where it unveiled its state-of-the-art AI diagnostic software. The event, held in the vibrant city of Marrakech, served as an excellent platform for TB-AI to present its innovative technology to a global audience, highlighting the software’s potential to transform the landscape of communicable disease diagnosis.

TB-AI’s participation in GITEX Africa 2024 marked a significant milestone for the startup. The company showcased its AI diagnostic software, designed to diagnose communicable diseases with remarkable speed and accuracy. The software delivers highly sensitive and specific results within minutes, significantly reducing human error and alleviating the human capacity burden in healthcare settings. Additionally, TB-AI’s solution is cost-effective, making it accessible to a wide range of healthcare providers.


By leveraging advanced GenAI algorithms, TB-AI’s software analyzes diagnostic data swiftly and accurately, ensuring timely intervention and treatment. This innovative approach enhances diagnostic precision, optimizes resource allocation, and ultimately improves patient outcomes.

Valuable Participation

Participating in GITEX Africa 2024 proved to be a worthwhile endeavor for TB-AI. The event offered an exceptional opportunity to engage with potential investors, partners, and industry leaders. The positive reception and significant interest in TB-AI’s technology underscored its potential impact on global healthcare.

“We are elated with the response TB-AI received at GITEX Africa 2024. The event provided a fantastic platform to showcase our cutting-edge AI diagnostic software to a diverse and influential audience,” said Dr. Hira Fareed, Founder&CEO at TB-AI. “The feedback and interest we garnered have been overwhelmingly positive, reaffirming our belief in the transformative power of our technology.”

Distributed by APO Group on behalf of GITEX Africa.

Dr. Hira Fareed
[email protected]



About TB-AI:
Based in Pakistan, TB-AI is dedicated to revolutionizing medical diagnostics through innovative AI solutions. The company’s AI diagnostic software aims to enhance the accuracy and efficiency of diagnosing communicable diseases, providing healthcare professionals with a powerful tool to improve patient care. By reducing human error and optimizing resource use, TB-AI strives to support public health initiatives and improve healthcare delivery worldwide.

Future Prospects:
Looking ahead, TB-AI remains committed to advancing its technology and expanding its impact. The connections made and insights gained at GITEX Africa 2024 will be instrumental in guiding the future development and implementation of TB-AI’s diagnostic solutions on a global scale.

For more information, please visit www.DHUB-AI.info or contact [email protected]